Medical Dosimetry
Volume 36, Issue 2 , Pages 206-212 , Summer 2011

Helical Tomotherapy Delivery of an IMRT Boost in Lieu of Interstitial Brachytherapy in the Setting of Gynecologic Malignancy: Feasibility and Dosimetric Comparison

  • Benjamin T. Gielda, M.D.

      Affiliations

    • Department of Radiation Oncology, Rush University Medical Center, Chicago IL
    • Corresponding Author InformationReprint requests to: Benjamin T. Gielda, M.D., 500 S. Paulina St., Ground Floor, Atrium Building, Rush University Medical Center, Chicago, IL 60612
    • ,
  • Anand P. Shah, M.D.

      Affiliations

    • Department of Radiation Oncology, Rush University Medical Center, Chicago IL
    • ,
  • James C. Marsh, M.D.

      Affiliations

    • Department of Radiation Oncology, Rush University Medical Center, Chicago IL
    • ,
  • Joseph P. Smart, (R.)T.T.

      Affiliations

    • Department of Radiation Oncology, Rush University Medical Center, Chicago IL
    • ,
  • Damian Bernard, Ph.D.

      Affiliations

    • Department of Radiation Oncology, Rush University Medical Center, Chicago IL
    • ,
  • Jacob Rotmensch, M.D.

      Affiliations

    • Section of Gynecologic Oncology, Rush University Medical Center, Chicago IL
    • ,
  • Katherine L. Griem, M.D., F.A.C.R.

      Affiliations

    • Department of Radiation Oncology, Rush University Medical Center, Chicago IL

Received 22 October 2009 ,Accepted 9 March 2010.

References 

  1. Concurrent chemoradiation for cervical cancer. National Cancer Institute Clinical Announcement. February 1999;
  2. Morris M, Eifel PJ, Lu J, et al. Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer. N. Engl. J. Med. 1999;340:1137–1143
  3. Rose PG, Bundy BN, Watkins EB, et al. Concurrent cisplatin based radiotherapy and chemotherapy for locally advanced cervical cancer. N. Engl. J. Med. 1999;340:1144–1153
  4. Keys HM, Bundy BN, Stehman FB, et al. Cisplatin, radiation and adjuvant hysterectomy compared with radiation and adjuvant hysterectomy for bulky stage IB cervical cancer. N. Engl. J. Med. 1999;340:1154–1161
  5. Perez CA, Grigsby PW, Chao KS, et al. Tumor size, irradiation dose, and long-term outcome of carcinoma of uterine cervix. Int. J. Radiat. Oncol. Biol. Phys. 1998;41:307–317
  6. Eifel PJ, Thoms WW, Smith TL, et al. The relationship between brachytherapy dose and outcome in patients with bulky endocervical tumors treated with radiation alone. Int. J. Radiat. Oncol. Biol. Phys. 1994;28:113–118
  7. Viswanathan AN, Cormack R, Holloway CL, et al. Magnetic resonance-guided interstitial therapy for vaginal recurrence of endometrial cancer. Int. J. Radiat. Oncol. Biol. Phys. 2006;66:91–99
  8. Weitmann HD, Knocke TH, Waldhäusl C, et al. Ultrasound-guided interstitial brachytherapy in the treatment of advanced vaginal recurrences from cervical and endometrial carcinoma. Strahlenther. Onkol. 2006;182:86–95
  9. Nag S, Yacoub S, Copeland LJ, et al. Interstitial brachytherapy for salvage treatment of vaginal recurrences in previously unirradiated endometrial cancer patients. Int. J. Radiat. Oncol. Biol. Phys. 2002;54:1153–1159
  10. Demanes DJ, Rodriguez RR, Bendre DD, et al. High dose rate transperineal interstitial brachytherapy for cervical cancer: High pelvic control and low complication rates. Int. J. Radiat. Oncol. Biol. Phys. 1999;45:105–112
  11. Syed AMN, Puthawala AA, Neblett D. Transperineal interstitial-intracavitary “Syed-Neblett” application in the treatment of carcinoma of the uterine cervix. Endocurie. Hypertherm. Oncol. 1998;2:1e13
  12. Nag S, Martinez-Monge R, Selman AE, et al. Interstitial brachytherapy in the management of primary carcinoma of the cervix and vagina. Gynecol. Oncol. 1998;70:27–32
  13. Syed AM, Puthawala AA, Abdelaziz NN, et al. Long-term results of low-dose-rate interstitial-intracavitary brachytherapy in the treatment of carcinoma of the cervix. Int. J. Radiat. Oncol. Biol. Phys. 2002;54:67–78
  14. Beriwal S, Bhatnagar A, Heron DE, et al. High-dose-rate interstitial brachytherapy for gynecologic malignancies. Brachytherapy. 2006;5:218–222
  15. Barraclough LH, Swindell R, Livsey JE, et al. External beam boost for cancer of the cervix uteri when intracavitary therapy cannot be performed. Int. J. Radiat. Oncol. Biol. Phys. 2008;71:772–778
  16. Ferreira PR, Braga-Filho A, Barletta A, et al. Radiation therapy alone in stage III-B cancer of the uterine cervix—a 17-year old experience in southern Brazil. Int. J. Radiat. Oncol. Biol. Phys. 1999;45:441–446
  17. Fuller DB, Naitoh J, Lee C, et al. Virtual HDR CyberKnife treatment for localized prostatic carcinoma: Dosimetry comparison with HDR brachytherapy and preliminary clinical observations. Int. J. Radiat. Oncol. Biol. Phys. 2008;70:1588–1597
  18. Aydogan B, Mundt AJ, Smith BD, et al. A dosimetric analysis of intensity-modulated radiation therapy (IMRT) as an alternative to adjuvant high-dose-rate (HDR) brachytherapy in early endometrial cancer patients. Int. J. Radiat. Oncol. Biol. Phys. 2006;65:266–273
  19. Assenholt MS, Petersen JB, Nielsen SK, et al. A dose planning study on applicator guided stereotactic IMRT boost in combination with 3D MRI based brachytherapy in locally advanced cervical cancer. Acta. Oncol. 2008;47:1337–1343
  20. Duan J, Kim RY, Elassal S, et al. Conventional high-dose-rate brachytherapy with concomitant complementary IMRT boost: a novel approach for improving cervical tumor dose coverage. Int. J. Radiat. Oncol. Biol. Phys. 2008;71:765–771
  21. Wahab SH, Malyapa RS, Mutic S, et al. A treatment planning study comparing HDR and AGIMRT for cervical cancer. Med. Phys. 2004;31:734–743
  22. Malhotra HK, Avadhani JS, deBoer SF, et al. Duplicating a tandem and ovoids distribution with intensity-modulated radiotherapy: a feasibility study. J. Appl. Clin. Med. Phys. 2007;8:2450
  23. Mollà M, Escude L, Nouet P, et al. Fractionated stereotactic radiotherapy boost for gynecologic tumors: An alternative to brachytherapy?. Int. J. Radiat. Oncol. Biol. Phys. 2005;62:118–124
  24. Sheng K, Molloy JA, Read PW. Intensity-modulated radiation therapy (IMRT) dosimetry of the head and neck: A comparison of treatment plans using linear accelerator-based IMRT and helical tomotherapy. Int. J. Radiat. Oncol. Biol. Phys. 2006;65:917–923
  25. van Vulpen M, Field C, Raaijmakers CP, et al. Comparing step-and-shoot IMRT with dynamic helical tomotherapy IMRT plans for head-and-neck cancer. Int. J. Radiat. Oncol. Biol. Phys. 2005;62:1535–1539
  26. Fiorino C, Dell'Oca I, Pierelli A, et al. Significant improvement in normal tissue sparing and target coverage for head and neck cancer by means of helical tomotherapy. Radiother. Oncol. 2006;78:276–282
  27. Shah AP, Strauss JB, Gielda BT, et al. Toxicity associated with bowel or bladder puncture during gynecologic interstitial brachytherapy. Int. J. Radiat. Oncol. Biol. Phys. 2010;77:171–179
  28. Pötter R, Haie-Meder C, van Limbergen E, et al. Recommendations from gynaecological (GYN) GEC ESTRO working group (II): Concepts and terms in 3D image-based treatment planning in cervix cancer brachytherapy-3D dose volume parameters and aspects of 3D image-based anatomy, radiation physics, radiobiology. Radiother. Oncol. 2006;78:67–77
  29. Lang S, Kirisits C, Dimopoulos J, et al. Treatment planning for MRI assisted brachytherapy of gynecologic malignancies based on total dose constraints. 2007;69:619–627
  30. Koom WS, Sohn DY, Kim JY, et al. Treatment planning for MRI assisted brachytherapy of gynecologic malignancies based on total dose constraints. Int. J. Radiat. Oncol. Biol. Phys. 2007;68:1446–1454
  31. Georg P, Kirisits C, Goldner G, et al. Correlation of dose-volume parameters, endoscopic and clinical rectal side effects in cervix cancer patients treated with definitive radiotherapy including MRI-based brachytherapy. Radiother. Oncol. 2009;91:173–180
  32. Chan LW, Xia P, Gottschalk AR. Proposed rectal dose constraints for patients undergoing definitive whole pelvic radiotherapy for clinically localized prostate cancer. Int. J. Radiat. Oncol. Biol. Phys. 2008;72:69–77
  33. Yaparpalvi R, Mutyala S, Gorla GR, et al. Point vs. volumetric bladder and rectal doses in combined intracavitary-interstitial high-dose-rate brachytherapy: Correlation and comparison with published Vienna applicator data. Brachytherapy. 2008;7:336–342
  34. Dimopoulos JC, Lang S, Kirisits C, et al. Dose-volume histogram parameters and local tumor control in magnetic resonance image-guided cervical cancer brachytherapy. Int. J. Radiat. Oncol. Biol. Phys. 2009;75:56–63
  35. Ash D, Al-Qaisieh B, Bottomley D, et al. The correlation between D90 and outcome for I-125 seed implant monotherapy for localised prostate cancer. Radiother. Oncol. 2006;79:185–189
  36. Goldner G, Tomicek B, Becker G, et al. Proctitis after external beam radiotherapy for prostate cancer classified by the “Vienna Rectoscopy Score” and correlated to the EORTC/RTOG Score for late rectal toxicity: Results of a prospective multicenter study in 166 patients. Int. J. Radiat. Oncol. Biol. Phys. 2007;67:78–83
  37. O'Brien PC, Hamilton CS, Denham JW, et al. Spontaneous improvement in late rectal mucosal changes after radiotherapy for prostate cancer. Int. J. Radiat. Oncol. Biol. Phys. 2004;58:75–80
  38. Wachter S, Gerstner N, Goldner G, et al. Endoscopic scoring of late rectal mucosal damage after conformal radiotherapy for prostatic carcinoma. Radiother. Oncol. 2000;54:11–19
  39. Vargas C, Martinez A, Kestin LL, et al. Dose-volume analysis of predictors for chronic rectal toxicity after treatment of prostate cancer with adaptive image-guided radiotherapy. Int. J. Radiat. Oncol. Biol. Phys. 2005;62:1297–1308
  40. Schubert LK, Westerly DC, Tomé WA, et al. A comprehensive assessment by tumor site of patient setup using daily MVCT imaging from more than 3,800 helical tomotherapy treatments. Int. J. Radiat. Oncol. Biol. Phys. 2009;73:1260–1269
  41. Chan P, Dinniwell R, Haider MA, et al. Inter- and intrafractional tumor and organ movement in patients with cervical cancer undergoing radiotherapy: A cinematic-MRI point-of-interest study. Int. J. Radiat. Oncol. Biol. Phys. 2008;70:1507–1515
  42. van de Bunt L, Jurgenliemk-Schulz IM, de Kort GA, et al. Motion and deformation of the target volumes during IMRT for cervical cancer: What margins do we need?. Radiother. Oncol. 2008;88:233–240
  43. Lim K, Kelly V, Stewart J, et al. Pelvic radiotherapy for cancer of the cervix: Is what you plan actually what you deliver?. Int. J. Radiat. Oncol. Biol. Phys. 2009;74:304–312
  44. Jhingran A, Eifel PJ. Perioperative and postoperative complications of intracavitary radiation for FIGO stage I–III carcinoma of the cervix. Int. J. Radiat. Oncol. Biol. Phys. 2000;46:1177–1183
  45. Lanciano R, Corn B, Martin E, et al. Perioperative morbidity of intracavitary gynecologic brachytherapy. Int. J. Radiat. Oncol. Biol. Phys. 1994;29:969–974

PII: S0958-3947(10)00032-4

doi: 10.1016/j.meddos.2010.03.005

Medical Dosimetry
Volume 36, Issue 2 , Pages 206-212 , Summer 2011

Article Tools

* Image Usage & Resolution